Toshiaki Iba
Toshiaki Iba is an expert in Hematology at Juntendo University Urayasu Hospital (Japan). As of November 2026, ScienceLeadR ranks Toshiaki Iba in the top 1% of experts worldwide for Embolism and Thrombosis, Coronavirus Infections and COVID-19. Toshiaki Iba has authored 353 publications, the most recent in 2026, and is an investigator in 1 clinical trial. SLR score: 1,414 (community average: 125). How the SLR is computed.
LeadR Profile
Hematology
Subspecialties: Critical Care
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1959 - 2026
Number : 353
Citations
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Sepsis-Induced Coagulopathy (SIC) Update 2026: Simplifying the Diagnosis and Dynamic Monitoring of Sepsis-Associated DIC. PMID 42962682 — anticoagulants, sepsis, diagnosis, therapeutics, thrombosis, hemostasis | Semin Thromb Hemost | 2026 | 0 |
| Proposal of simplified sepsis-induced coagulopathy criteria (SIC-2) for the detection of early-phase disseminated intravascular coagulation in sepsis. PMID 42498136 — mortality, blood coagulation, multiple organ failure, fibrin fibrinogen degradation products, sepsis, intensive care units, thrombosis, prothrombin time, disseminated intravascular coagulation | J Thromb Haemost | 2026 | 0 |
| Ischemic Limb Necrosis and Symmetrical Peripheral Gangrene During Vasopressor Support in Severe Shock States: Thromboinflammatory Microvascular Injury as the Pathogenic Mechanism. PMID 42760619 — anticoagulants, shock, septic, liver, critical illness, necrosis, therapeutics, thrombosis, tissues, gangrene, ischemia, disseminated intravascular coagulation | Eur Heart J Cardiovasc Pharmacother | 2026 | 0 |
| Granulomonocytapheresis for Sepsis: Mechanistic Rationale, Therapeutic Potential, and Potential Concerns in Thromboinflammatory Critical Illness. PMID 42698727 — cytokines, cells, monocytes, blood component removal, granulocytes, sepsis, critical illness, leukocytes, therapeutics, thrombosis | Juntendo Med J | 2026 | 0 |
| Integrated Model Linking Hemolysis, NETosis, Ferroptosis, Lysosomal Dysfunction, and DIC in Sepsis. PMID 42532121 — cells, hemoglobins, fibrinolysis, stress, physiological, neutrophils, ferroptosis, oxidative stress, heme, sepsis, ferritins, hemolysis, thrombosis, hemostasis | Semin Thromb Hemost | 2026 | 1 |
Clinical Studies 1
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
LeadR Networks
Main global connection map